Literature DB >> 9373486

Presentation of retinoblastoma as phthisis bulbi.

P B Mullaney1, Z A Karcioglu, S al-Mesfer, E B Abboud.   

Abstract

PURPOSE: We sought to determine the incidence of retinoblastoma patients who presented with phthisis bulbi.
METHODS: The medical records of 272 patients in the King Khaled Eye Specialist Hospital Retinoblastoma Registry were retrospectively studied. Clinical records, radiological investigations and histopathological slides were reviewed.
RESULTS: We found that 2.7% of patients had retinoblastoma coincident with phthisis bulbi. Five of 10 patients had bilateral retinoblastoma; in the others it was unilateral. Radiologically, intraocular calcification was present in all except one case. All enucleated phthisical globes had residual viable tumour cells; optic nerve extension was found in 2 patients who had long-standing phthisis bulbi.
CONCLUSION: Phthisis bulbi is an uncommon presenting sign of retinoblastoma which often occurs after an ocular inflammatory episode possibly related to intraocular tumour infarction. In most cases the tumour is not visible because of intraocular disruption. That every enucleated eye in this series harboured well-differentiated tumour cells underlies the seriousness with which phthisis bulbi of unknown origin in children should be investigated for retinoblastoma.

Entities:  

Mesh:

Year:  1997        PMID: 9373486     DOI: 10.1038/eye.1997.85

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  2 in total

1.  A long follow-up of a patient with bilateral retinoblastoma who underwent globe-preserving therapy and had metastasis after 72mo.

Authors:  Yi Zhang; Dong-Sheng Huang; Wei-Ling Zhang; Yi-Zhuo Wang; Yan Zhou; Pin-Wei Zhang; Tao Han; Jian-Min Ma; Ji-Tong Shi; Xin Ge
Journal:  Int J Ophthalmol       Date:  2017-10-18       Impact factor: 1.779

2.  A case of retinoblastoma resulting in phthisis bulbi after proton beam radiation therapy.

Authors:  Norihiko Nakagawa; Takeshi Morimoto; Takako Miyamura; Shigenobu Suzuki; Hiroshi Shimojo; Kohji Nishida
Journal:  Am J Ophthalmol Case Rep       Date:  2022-09-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.